These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2478814)

  • 1. The efficacy of xamoterol in heart failure of ischemic origin.
    Marlow HF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S69-72. PubMed ID: 2478814
    [No Abstract]   [Full Text] [Related]  

  • 2. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
    Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
    Vigholt-Sørensen E; Faergeman O; Snow HM
    Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
    European 'Corwin' Study Group
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
    [No Abstract]   [Full Text] [Related]  

  • 7. New evidence on xamoterol.
    Lancet; 1990 Jul; 336(8706):24. PubMed ID: 1973213
    [No Abstract]   [Full Text] [Related]  

  • 8. Xamoterol in heart failure.
    von Olshausen K
    Lancet; 1988 May; 1(8595):1162. PubMed ID: 2896976
    [No Abstract]   [Full Text] [Related]  

  • 9. Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988.
    Barnett DB; Breckenridge A
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):1S-91S. PubMed ID: 2572249
    [No Abstract]   [Full Text] [Related]  

  • 10. Xamoterol in severe heart failure.
    Ikram H; Crozier IG
    Lancet; 1990 Aug; 336(8713):517-8. PubMed ID: 1975033
    [No Abstract]   [Full Text] [Related]  

  • 11. Xamoterol versus digoxin in heart failure.
    Lancet; 1988 Apr; 1(8590):877. PubMed ID: 2895376
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
    Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R
    Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac insufficiency. Current treatment].
    Aumont MC; Castaigne A
    Rev Prat; 1988 Feb; 38(5 Suppl):5-11. PubMed ID: 2895497
    [No Abstract]   [Full Text] [Related]  

  • 14. Xamoterol--more trouble than it's worth?
    Drug Ther Bull; 1990 Jul; 28(14):53-4. PubMed ID: 1983395
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
    Sørensen EV; Faergeman O; Day MA; Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term studies with xamoterol in heart failure.
    Waller DG
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
    Watanabe K; Hirokawa Y; Shibata A
    J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
    Sashida H; Sakai K; Hino T; Abiko Y
    Pharmacology; 1986; 33(6):301-10. PubMed ID: 2882527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.